Trial Evaluating the Efficacy of Local Budesonide Therapy in the Management of Hyposmia in COVID-19 Patients Without Signs of Severity
Last updated on July 2021Recruitment
- Recruitment Status
- Active, not recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Anosmia
- Budesonide
- Olfaction Disorders
- Sars Cov 2
- Type
- Interventional
- Phase
- Phase 3
- Design
- Allocation: RandomizedIntervention Model: Parallel AssignmentIntervention Model Description: Patients with persistent hyposmia related to a SARS-CoV-2 infectionMasking: Single (Participant)Masking Description: Patients with persistent hyposmia related to a SARS-CoV-2 infectionPrimary Purpose: Treatment
Participation Requirements
- Age
- Between 18 years and 125 years
- Gender
- Both males and females
Description
This is a multicenter randomized trial to evaluate the efficacy of local budesonide (nasal irrigation) in the management of persistent hyposmia in COVID-19 patients.
This is a multicenter randomized trial to evaluate the efficacy of local budesonide (nasal irrigation) in the management of persistent hyposmia in COVID-19 patients.
Tracking Information
- NCT #
- NCT04361474
- Collaborators
- Hopital Lariboisière
- Investigators
- Principal Investigator: Mary DAVAL Hopital Fondation A de Rothschild